{"id":"W3135371333","doi":"10.3233/kca-210110","title":"Real-Word Experience of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis)","year":2021,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"CancerCare Manitoba; St Joseph's Health Centre; University of Ottawa; Sunnybrook Health Science Centre; Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Toronto; Western University; Princess Margaret Cancer Centre; University of Calgary; Centre hospitalier universitaire de Québec; London Health Sciences Centre; Alberta Health Services; McMaster University; University of Manitoba; Juravinski Cancer Centre; Université Laval; University of Alberta","funders":"Genentech; Ipsen; Astellas Pharma; Eisai; Karyopharm Therapeutics; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Exelixis; GlaxoSmithKline","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Kidney cancer; Internal medicine; Cancer; Oncology; Tyrosine-kinase inhibitor; Population; Urology; Surgery; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002792727,0.0003132404,0.0005945812,0.0001868686,0.0001440827,0.00005686002,0.0002359829,0.0001242993,0.0004576178],"category_scores_gemma":[0.0004025935,0.0002331971,0.0001449814,0.0007519791,0.0001193016,0.0002617369,0.00006387375,0.0003092846,0.00003067341],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001931526,"about_ca_system_score_gemma":0.01012211,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8798737,"about_ca_topic_score_gemma":0.4029926,"domain_scores_codex":[0.9972295,0.0001790247,0.0009401884,0.0004425809,0.0006594352,0.0005493421],"domain_scores_gemma":[0.9972461,0.0001255184,0.0003818143,0.0008344064,0.000416204,0.0009958871],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004071716,0.0003857704,0.621343,0.00273692,0.000819444,0.003095264,0.1117646,0.000995275,0.04911506,0.0004606628,0.193248,0.01196435],"study_design_scores_gemma":[0.01282351,0.0001789033,0.5511186,0.003097568,0.0007270616,0.00007172352,0.008864079,0.001501897,0.3296446,0.00001167036,0.09131582,0.0006446504],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9718836,0.001351613,0.00000611911,0.004795017,0.0007326995,0.0008105768,0.003915533,0.00003169226,0.01647314],"genre_scores_gemma":[0.9947554,0.0003810527,0.0004226752,0.002285492,0.0001914703,0.0003684856,0.0007382254,0.00003101129,0.0008261832],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4768811,"threshold_uncertainty_score":0.9954896,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02726936905650948,"score_gpt":0.2753342238878853,"score_spread":0.2480648548313758,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}